A study by Yale Department of Psychiatry researchers addresses concerns associated with the prescription of antipsychotic, sedative, and anxiolytic medications in the initiation of pharmacotherapy treatment for post-traumatic stress disorder (PTSD).
Researchers studied U.S. veterans who served in Iraq and Afghanistan, and who received a PTSD diagnosis between 2008 and 2011. They analyzed the relationship between symptoms and the medications prescribed to the veterans, and wrote that the results of their study may help to inform prescribing patterns for PTSD.
The study was published in the British Journal of Psychiatry Open. The first author was Ilan Harpaz-Rotem, PhD, associate professor of psychiatry. The other authors were Robert Rosenheck, Somaia Mohamed, Robert Pietrzak, and Rani Hoff.